Dr. Kevin Biglan is a neurologist and the associate chair of clinical research for the Department of Neurology at the University of Rochester with expertise in the assessment and management of Parkinson’s disease and clinical research with nearly 13 years of experience in the conduct and analysis of clinical trials. He is actively involved in clinical trials aimed at identifying therapies that slow progression of Parkinson’s disease and Huntington’s disease and in designing trials and identifying therapies aimed at delaying onset of disease in Huntington’s disease. He completed his medical school residency at Thomas Jefferson University, his fellowship in movement disorders and experimental therapeutics and his Master of Public Health at the University of Rochester.